Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) has provided an update.
Race Oncology Ltd has announced the quotation of 122,829 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 6, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional value to its stakeholders by leveraging its securities for potential growth and expansion in the oncology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the oncology industry, focusing on the development and commercialization of cancer treatments. The company is known for its innovative approaches in cancer therapy and aims to make significant impacts in the healthcare market.
Average Trading Volume: 510,773
Technical Sentiment Signal: Buy
Current Market Cap: A$585.2M
Learn more about RAC stock on TipRanks’ Stock Analysis page.